Related references
Note: Only part of the references are listed.GVHD Prophylaxis 2020
Mahasweta Gooptu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Distribution of Transplantation-Associated Thrombotic Microangiopathy (TA-TMA) and Comparison between Renal TA-TMA and Intestinal TA-TMA: Autopsy Study
Rin Yamada et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells
Christin Riegel et al.
LEUKEMIA (2020)
FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Donna Przepiorka et al.
ONCOLOGIST (2020)
A Phase 2 Study of F-652, a Novel Tissue-Targeted Recombinant Human Interleukin-22 (IL-22) Dimer, for Treatment of Newly Diagnosed Acute Gvhd of the Lower GI Tract
Doris M. Ponce et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease
Joanne Kurtzberg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
Jonathan U. Peled et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hematopoietic Cell Transplantation Version 2.2020
Ayman Saad et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin
Stephanie C. Gergoudis et al.
BLOOD ADVANCES (2020)
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract
Alex Ganetsky et al.
BONE MARROW TRANSPLANTATION (2019)
T Cell Costimulation Blockade with CTLA4-Ig (Abatacept) for Acute Gvhd Prevention in HLA Matched and Mismatched Unrelated Donor Transplantation: Results of the First Phase 2 Trial
Ben K. Watkins et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
T Cell Recruitment to the Intestinal Stem Cell Compartment Drives Immune-Mediated Intestinal Damage after Allogeneic Transplantation
Ya-Yuan Fu et al.
IMMUNITY (2019)
The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease
Lu Zhao et al.
STEM CELL RESEARCH & THERAPY (2019)
Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease
Christoph Groth et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Safety and Effectiveness of Vedolizumab in Patients with Steroid- Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review
Yngvar Floisand et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Anti-a4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease
Ivetta Danylesko et al.
BONE MARROW TRANSPLANTATION (2019)
T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage
S. Takashima et al.
SCIENCE IMMUNOLOGY (2019)
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
Hrishikesh K. Srinagesh et al.
BLOOD ADVANCES (2019)
Phase II Trial of Natalizumab (Tysabri®) with Corticosteroids as Initial Treatment of Gastrointestinal Acute Graft Versus Host Disease
Natasha Kekre et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease
John M. Magenau et al.
BLOOD (2018)
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
Hannah Major-Monfried et al.
BLOOD (2018)
Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease
Dongchang Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant
Ying Taur et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Microbial metabolite sensor GPR43 controls severity of experimental GVHD
Hideaki Fujiwara et al.
NATURE COMMUNICATIONS (2018)
Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD
Sarah A. Wall et al.
BLOOD ADVANCES (2018)
IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
Brian C. Betts et al.
HAEMATOLOGICA (2017)
IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
Brian C. Betts et al.
HAEMATOLOGICA (2017)
Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation
Daniela Weber et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Mechanisms and consequences of Jak-STAT signaling in the immune system
Alejandro V. Villarino et al.
NATURE IMMUNOLOGY (2017)
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival
Matthew J. Hartwell et al.
JCI INSIGHT (2017)
Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
Claudio G. Brunstein et al.
BLOOD (2016)
Tocilizumab for steroid refractory acute graft-versus-host disease
Julianna V. F. Roddy et al.
LEUKEMIA & LYMPHOMA (2016)
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
Andrew C. Harris et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Role of the intestinal mucosa in acute gastrointestinal GVHD
Jonathan U. Peled et al.
BLOOD (2016)
Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut
Kazuhiko Kakihana et al.
BLOOD (2016)
Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
Nathan D. Mathewson et al.
NATURE IMMUNOLOGY (2016)
A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality
Margaret L. MacMillan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Post-Transplant High-Dose Cyclophosphamide for the Prevention of Graft-versus-Host Disease
Ahmad Samer Al-Homsi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment
George B. McDonald et al.
BLOOD (2015)
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R. Zeiser et al.
LEUKEMIA (2015)
ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease
Jilu Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study
John E. Levine et al.
LANCET HAEMATOLOGY (2015)
Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
Xiaomei Chen et al.
PLOS ONE (2015)
Targeting the IL17 Pathway for the Prevention of Graft-Versus-Host Disease
Anniek B. van der Waart et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease
Ernst Holler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
Ying Taur et al.
BLOOD (2014)
Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
Silvia Spoerl et al.
BLOOD (2014)
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial
Glen A. Kennedy et al.
LANCET ONCOLOGY (2014)
Graft-versus-Host Disease: State of the Science
Amin M. Alousi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-Up of a Randomized Study
Tapani Ruutu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo
Annkristin Heine et al.
BLOOD (2013)
Expression of α4β7 integrin on memory CD8+ T cells at the presentation of acute intestinal GVHD
Y-B Chen et al.
BONE MARROW TRANSPLANTATION (2013)
ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death
Mark T. Vander Lugt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
Paul J. Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
Oliver C. Goodyear et al.
BLOOD (2012)
Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study
John E. Levine et al.
BLOOD (2012)
Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins
Yoshihiro Eriguchi et al.
BLOOD (2012)
Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Ying Taur et al.
CLINICAL INFECTIOUS DISEASES (2012)
Interleukin-22 Protects Intestinal Stem Cells from Immune-Mediated Tissue Damage and Regulates Sensitivity to Graft versus Host Disease
Alan M. Hanash et al.
IMMUNITY (2012)
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
Robert R. Jenq et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Structure, function and diversity of the healthy human microbiome
Curtis Huttenhower et al.
NATURE (2012)
Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation
Isao Tawara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease
William R. Drobyski et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
Claudio G. Brunstein et al.
BLOOD (2011)
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease
James L. M. Ferrara et al.
BLOOD (2011)
Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new
James M. Coghill et al.
BLOOD (2011)
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Mauro Di Ianni et al.
BLOOD (2011)
Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and Homeostasis
Lydia Durant et al.
IMMUNITY (2010)
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis.
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Proinflammatory Role of the Th17 Cytokine Interleukin-22 in Collagen-Induced Arthritis in C57BL/6 Mice
Lies Geboes et al.
ARTHRITIS AND RHEUMATISM (2009)
A biomarker panel for acute graft-versus-host disease
Sophie Paczesny et al.
BLOOD (2009)
Ex vivo expanded human CD4+CD25+Foxp3+regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD)
Tinghua Cao et al.
CELLULAR IMMUNOLOGY (2009)
Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial
M. Caproni et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Geethanjali Pickert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
α-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood
Gregory B. Pott et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
Cyclophosphamide and cancer: golden anniversary
Ashkan Emadi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease
Lauren A. Zenewicz et al.
IMMUNITY (2008)
Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle
Rajesh Ramasamy et al.
TRANSPLANTATION (2007)
Human mesenchymal stem cells modulate B-cell functions
A Corcione et al.
BLOOD (2006)
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
M Edinger et al.
NATURE MEDICINE (2003)
Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction
M Murai et al.
NATURE IMMUNOLOGY (2003)
Immunobiology of acute graft-versus-host disease
P Reddy et al.
BLOOD REVIEWS (2003)
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation
T Ruutu et al.
BLOOD (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
A Bartholomew et al.
EXPERIMENTAL HEMATOLOGY (2002)
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide
PV O'Donnell et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment
S Arai et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Share Paper
